Moderna’s mRNA Flu Shot Gets FDA Approval | Detroit News

The FDA just approved Moderna’s new mRNA flu vaccine, mFLUSIVA, for people 50 and older — the first time mRNA tech is used in an approved seasonal flu shot. Designed to be faster and more effective than egg-based vaccines, it could revolutionize how we respond to flu outbreaks. Despite past skepticism from within HHS, strong trial results show better protection for seniors, with common side effects like sore arm or fatigue. It’s set to roll out in the 2026-2027 flu season. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/cd5f4dde472087aa